Clinical Trial Update: Cholesterol-Lowering Atherosclerosis Study (CLAS) [Phase 3]

View source ↗

Summary

Phase 3 Cholesterol-Lowering Atherosclerosis Study (CLAS) has completed the trial, per the update; the snippet provides status but no efficacy results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arterial Occlusive Disease
• Atherosclerosis
• Cardiovascular Disease
• Carotid Artery Disease
• Cerebral Arteriosclerosis
• Cerebrovascular Disease
• Coronary Artery Disease
• Myocardial Ischemia

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Arterial Occlusive Diseases, Cardiovascular Diseases | Phase 3 | Status: COMPLETED